The short-term and long-term effects of tolvaptan in patients with heart failure: a meta-analysis of randomized controlled trials Bo XiongYuwen HuangJing Huang OriginalPaper 03 September 2015 Pages: 633 - 642
Heart failure preserved ejection fraction (HFpEF): an integrated and strategic review Carolyn L. LekavichDebra J. BarksdaleJia-Rong Wu OriginalPaper 24 September 2015 Pages: 643 - 653
Care-seeking decisions for worsening symptoms in heart failure: a qualitative metasynthesis S. E. IvynianM. DiGiacomoP. J. Newton OriginalPaper 11 October 2015 Pages: 655 - 671
The gap between policy and practice: a systematic review of patient-centred care interventions in chronic heart failure P. M. KaneF. E. M. MurtaghB. A. Daveson OriginalPaper Open access 05 October 2015 Pages: 673 - 687
Fabry’s disease: an example of cardiorenal syndrome type 5 Aashish SharmaMarco SartoriClaudio Ronco OriginalPaper 01 August 2015 Pages: 689 - 708
Resuscitation of a dead cardiomyocyte George H. KunkelPankaj ChaturvediSuresh C. Tyagi OriginalPaper 27 August 2015 Pages: 709 - 719
Chemotherapy-induced cardiomyopathy Angela Y. HigginsThomas D. O’HalloranJames D. Chang OriginalPaper 03 September 2015 Pages: 721 - 730
Myocardial interstitial remodelling in non-ischaemic dilated cardiomyopathy: insights from cardiovascular magnetic resonance Andrea BarisonChrysanthos GrigoratosGiovanni Donato Aquaro OriginalPaper 30 September 2015 Pages: 731 - 749
Letter to the Editor regarding the article “Left ventricular assist devices: a kidney’s perspective” Timothy K. Cooper Letter 19 September 2015 Pages: 751 - 752
Absence of structural lesions in human renal arcuate arteries after LVAD implantation: response to a letter regarding “left ventricular assist devices: a kidney’s perspective” Tycho R. TrompTri Q. NguyenJaap A. Joles Letter 22 September 2015 Pages: 753 - 754